Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03838367
Title Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors CytoDyn, Inc.
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Leronlimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.